CHRONIC GOUT
Clinical trials for CHRONIC GOUT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GOUT trials appear
Sign up with your email to follow new studies for CHRONIC GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for Tough-to-Treat gout
Disease control CompletedThis study tested a gout medication called pegloticase (KRYSTEXXA) given every 4 weeks along with weekly methotrexate in 50 adults with chronic gout that did not respond to standard treatments. The goal was to see if this combination could lower uric acid levels and be safe. Resu…
Matched conditions: CHRONIC GOUT
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated May 17, 2026 10:25 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called SEL-212 in 112 adults with chronic gout that standard treatments couldn't control. Participants received one of two doses of SEL-212 or a placebo every 28 days for about 6 months. The main goal was to see if SEL-212 could lower and keep uri…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New gout drug shows promise in phase 3 trial
Disease control CompletedThis study tested a new medicine called SEL-212 in 153 adults with chronic gout that did not get better with standard treatments. The goal was to see if SEL-212 could lower uric acid levels in the blood to a safe range and keep them there for at least 80% of the time over six mon…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 04, 2026 16:24 UTC